Proteomics International (ASX:PIQ) featured on Channel 7’s 4pm and 6pm news bulletins discussing PromarkerEndo, the Company’s prototype blood-test for diagnosing endometriosis.
Proteomics International has developed a prototype diagnostic blood test for endometriosis, PromarkerEndo. In a clinical validation study with over 900 participants, the test accurately identified up to 90% of patients, offering a breakthrough test for early screening of the disease.
